The quality of antimicrobial susceptibility test discs and implications for clinical outcomes

Area of Science:

• Clinical microbiology
• Antimicrobial susceptibility testing
• Medical device quality control

Background:

• Disc diffusion is a primary method for assessing antibiotic activity in clinical settings.
• Current disc diffusion protocols lack validation and standardization.
• The quality of manufactured antibiotic discs is poorly understood, posing risks to patient outcomes.

Purpose of the Study:

• To highlight the deficiencies in current antibiotic disc diffusion methods.
• To underscore the lack of quality control and evidence-based assessment for these critical medical devices.
• To address the potential impact on clinical outcomes and antimicrobial resistance.

Main Methods:

• Review of existing literature and data on antibiotic disc quality.
• Analysis of current standards and regulatory oversight for medical devices in microbiology.
• Comparison of harmonization efforts between major standardization bodies (EUCAST and CLSI).

Main Results:

• A significant proportion of antibiotic discs fail to meet specifications.
• Disc diffusion assays are poor predictors of clinical treatment success.
• Major standardization bodies (EUCAST and CLSI) show a lack of harmonization, indicating systemic flaws.

Conclusions:

• The scientific rigor in antibiotic disc diffusion testing is insufficient.
• Inadequate quality control of antibiotic discs may lead to adverse clinical outcomes.
• Systemic flaws and lack of standardization contribute to the emergence of antimicrobial resistance.